Clinical Trial: Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD

U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07059637) titled 'Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD' on July 08.

Brief Summary: Sarcopenia, or skeletal muscle loss, impacts up to 40% of COPD patients and is a major cause for morbidity and mortality. Despite the high clinical significance of sarcopenia in COPD, the diagnosis remains elusive because accurate measures of skeletal muscle are not tested during routine clinical care. Our goal is to use evidence-based strategies to diagnose and treat sarcopenia due to COPD. Our multidisciplinary team includes a pulmonologist, pharmacist, COPD nurse, and COPD coordinator. We anticipate that our ap...